{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Generics, Biosimilars and Specialty Medicines",
    "sector_kpis": {
      "kpi_1": "R&D Spend: 7-8% of Revenue",
      "kpi_2": "US Generic Business Growth: 15-18% YoY",
      "kpi_3": "EBITDA Margin: 25.5%"
    },
    "moat_rating": "Narrow",
    "competitive_position": "CHALLENGER"
  },
  "_cached_at": "2025-12-31T13:15:21.750880",
  "_symbol": "ZYDUSLIFE"
}